Chemical Complementarity of Tumor Resident, Adaptive Immune Receptor CDR3s and Previously Defined Hepatitis C Virus Epitopes Correlates with Improved Outcomes in Hepatocellular Carcinoma.

Autor: Song JJ; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA., Chobrutskiy A; Department of Pediatrics, Oregon Health and Science University Hospital, Portland, Oregon, USA., Chobrutskiy BI; Department of Internal Medicine, Oregon Health and Science University Hospital, Portland, Oregon, USA., Cios KJ; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA., Huda TI; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA., Eakins RA; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA., Diaz MJ; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA., Blanck G; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA.; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.

Publikováno v: Viral immunology [Viral Immunol] 2023 Dec; Vol. 36 (10), pp. 669-677. Date of Electronic Publication: 2023 Dec 05.

Bacterial Sequencing Reads in Blood Exome Files from Melanoma and Cervical Cancer Patients are Associated with Cancer Recurrence.

Autor: Quach JU; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs Bd. MDC7, Tampa, FL, 33612, USA., Diaz MJ; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs Bd. MDC7, Tampa, FL, 33612, USA., Huda TI; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs Bd. MDC7, Tampa, FL, 33612, USA., Kinskey JC; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, 77030, USA., Zaman S; Department of Internal Medicine, Yale University, New Haven, CT, 06520, USA., Desantis JE; Research Computing, University of South Florida, Tampa, FL, 33620, USA., Cios KJ; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs Bd. MDC7, Tampa, FL, 33612, USA., Blanck G; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs Bd. MDC7, Tampa, FL, 33612, USA. gblanck@usf.edu.; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 33612, USA. gblanck@usf.edu.

Publikováno v: Molecular biotechnology [Mol Biotechnol] 2023 Sep; Vol. 65 (9), pp. 1476-1484. Date of Electronic Publication: 2023 Jan 18.

Chemical Complementarity of Breast Cancer Resident, T-Cell Receptor CDR3 Domains and the Cancer Antigen, ARMC3, is Associated With Higher Levels of Survival and Granzyme Expression.

Autor: Pakasticali N; Department of Pathology, Morsani College of Medicine, University of South Florida, Tampa, FL, USA., Chobrutskiy A; Department of Pediatrics, Oregon Health and Science University Hospital, Portland, OR, USA., Patel DN; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA., Hsiang M; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA., Zaman S; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA., Cios KJ; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA., Blanck G; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Chobrutskiy BI; Department of Internal Medicine, Oregon Health and Science University Hospital, Portland, OR, USA.

Publikováno v: Cancer informatics [Cancer Inform] 2023 Jun 01; Vol. 22, pp. 11769351231177269. Date of Electronic Publication: 2023 Jun 01 (Print Publication: 2023).

Electrostatic Complementarities of Glioblastoma-Resident T-Cell Receptors and Cancer Testis Antigens Linked to Poor Outcomes and High Levels of Sphingosine Kinase-2 Expression.

Autor: Arias MA; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA., Cios KJ; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA., Kacsoh DB; College of Medicine, University of Central Florida, Orlando, FL 32827, USA., Montgomery BE; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA., Song JJ; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA., Patel AR; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA., Chobrutskiy A; Department of Pediatrics, Oregon Health and Science University Hospital, Portland, OR 97239, USA., Chobrutskiy BI; Internal Medicine, Oregon Health and Science University Hospital, Portland, OR 97239, USA., Blanck G; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA.; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.

Publikováno v: Biology [Biology (Basel)] 2023 Apr 10; Vol. 12 (4). Date of Electronic Publication: 2023 Apr 10.

Extrinsic interactions in the microenvironment in vivo activate an antiapoptotic multidrug-resistant phenotype in CLL.

Autor: Jayappa KD; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA.; Beirne B. Carter Center for Immunology Research, Charlottesville, VA.; Cancer Center, University of Virginia, Charlottesville, VA., Gordon VL; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA.; Beirne B. Carter Center for Immunology Research, Charlottesville, VA.; Cancer Center, University of Virginia, Charlottesville, VA., Morris CG; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA.; Beirne B. Carter Center for Immunology Research, Charlottesville, VA.; Cancer Center, University of Virginia, Charlottesville, VA., Wilson B; Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA., Shetty BD; One Health Institute, School of Veterinary Medicine, University of California Davis, Davis, CA; and., Cios KJ; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA.; Beirne B. Carter Center for Immunology Research, Charlottesville, VA., Arora PC; Division of Hematology/Oncology, University of Virginia School of Medicine, Charlottesville, VA., Isaac KM; Division of Hematology/Oncology, University of Virginia School of Medicine, Charlottesville, VA., Saha S; Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA., Bender TP; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA.; Beirne B. Carter Center for Immunology Research, Charlottesville, VA., Williams ME; Cancer Center, University of Virginia, Charlottesville, VA.; Division of Hematology/Oncology, University of Virginia School of Medicine, Charlottesville, VA., Portell CA; Cancer Center, University of Virginia, Charlottesville, VA.; Division of Hematology/Oncology, University of Virginia School of Medicine, Charlottesville, VA., Weber MJ; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA.; Beirne B. Carter Center for Immunology Research, Charlottesville, VA.; Cancer Center, University of Virginia, Charlottesville, VA.

Publikováno v: Blood advances [Blood Adv] 2021 Sep 14; Vol. 5 (17), pp. 3497-3510.